MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker

被引：1
|
作者：
Shimabukuro, Michio [1 ,2 ]
机构：
[1] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, Fukushima, Japan
[2] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, 1 Hikarigaoka, Fukushima 9601295, Japan
来源：
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 2023年 / 30卷 / 08期
关键词：
CARDIOVASCULAR RISK; DISEASE;
D O I：
10.5551/jat.ED227
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：853 / 854
页数：2
相关论文
共 50 条
  • [1] PLASMA HEPARIN COFACTOR-II IN ALCOHOLIC LIVER-DISEASE
    ANDERSSON, TR
    BELL, H
    JOURNAL OF HEPATOLOGY, 1988, 7 (01) : 79 - 84
  • [2] ASSAY OF DERMATAN SULFATE COFACTOR (HEPARIN COFACTOR-II) ACTIVITY IN HUMAN-PLASMA
    ABILDGAARD, U
    LARSEN, ML
    THROMBOSIS RESEARCH, 1984, 35 (03) : 257 - 266
  • [3] Imidazolium salts as novel anti-liver fibrosis agents
    Zhuo, L.
    Zhang, C.
    Ding, Z. B.
    Kng, Y. L.
    Suhaimi, N-A M.
    Zhang, Y. G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A142 - A142
  • [4] Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles
    Alya Elzoheiry
    Esraa Ayad
    Nahed Omar
    Kadry Elbakry
    Ayman Hyder
    Scientific Reports, 12
  • [5] Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles
    Elzoheiry, Alya
    Ayad, Esraa
    Omar, Nahed
    Elbakry, Kadry
    Hyder, Ayman
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Synthesis and anti-liver fibrosis activity of imidazole and thiazole compounds containing amino acids
    Meng, Yu-Qing
    Ren, Jie
    Sun, Jing-Xin
    Guo, Fang-Yan
    Min, Jun-Zhe
    Nan, Ji-Xing
    Quan, Ji-Shan
    Lian, Li-Hua
    Jin, Cheng-Hua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 269
  • [7] Enhancement of heparin cofactor II anticoagulant activity
    Bauman, SJ
    Church, FC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34556 - 34565
  • [8] Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Hara, Tomoyo
    Uemoto, Ryoko
    Sekine, Akiko
    Mitsui, Yukari
    Masuda, Shiho
    Yamagami, Hiroki
    Kurahashi, Kiyoe
    Yoshida, Sumiko
    Otoda, Toshiki
    Yuasa, Tomoyuki
    Kuroda, Akio
    Ikeda, Yasumasa
    Endo, Itsuro
    Honda, Soichi
    Yoshimoto, Katsuhiko
    Kondo, Akira
    Tamaki, Toshiaki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    Abe, Masahiro
    Aihara, Ken-ich
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (08) : 871 - 883
  • [9] Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats
    Chun-Yu Liu
    World Journal of Gastroenterology, 2005, (37) : 5782 - 5786
  • [10] Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives
    Lv, Miao
    Guo, Simin
    Yang, Hexian
    Wang, Yongjian
    Li, Yiming
    Li, Yang
    Yi, Hong
    He, Hongwei
    Li, Zhuorong
    MOLECULES, 2024, 29 (19):
12345